Table 4.
Infection Rates Before and After Ajwa Intake Among 12 Randomly Screened Pediatric Oncology Patients.
| Before Ajwa Intake |
After Ajwa Intake |
|||
|---|---|---|---|---|
| Mean ± SD | Range | Mean ± SD | Range | |
| Klebsiella pneumoniae | 0.6 ± 0.9 | 0-3 | 0.2 ± 0.4 | 0-1 |
| K pneumoniae (ESBL) | 0.8 ± 2.3 | 0-8 | 0.1 ± 0.3 | 0-1 |
| K oxytoca | — | — | — | - |
| Escherichia coli | 0.7 ± 1.0 | 0-3 | 0.4 ± 0.5 | 0-1 |
| Escherichia coli (ESBL) | 0.4 ± 0.9 | 0-3 | 0.3 ± 0.5 | 0-1 |
| Proteus mirabilis | 0.3 ± 0.9 | 0-3 | 0.1 ± 0.3 | 0-1 |
| Spice organisms | 0.2 ± 0.4 | 0-1 | 0.2 ± 0.4 | 0-1 |
| Pseudomonas aeruginosa | 1.5 ± 4.6 | 0-16 | 0 | 0 |
| Pseudomonas species | 0.1 ± 0.3 | 0-1 | 0 | 0 |
| Acinetobacter baumannii | 0.4 ± 0.8 | 0-2 | 0.3 ± 0.7 | 0-2 |
| Stenotrophomonas maltophilia | — | — | — | - |
| Coagulase negative Staphylococcus | 1.8 ± 4.8 | 0-17 | 0.3 ± 0.5 | 0-1 |
| Staphylococcus aureus (MSSA) | 0.2 ± 0.6 | 0-3 | 0 | 0 |
| Staphylococcus aureus (MRSA) | 0.1 ± 0.3 | 0-1 | 0.1 ± 0.3 | 0-1 |
| Enterococcus faecalis | 0.3 ± 0.5 | 0-1 | 0 | 0 |
| Enterococcus faecium | 0.4 ± 1.4 | 0-5 | 0 | 0 |
| Streptococcus viridans group | 0.1 ± 0.3 | 0-1 | 0.1 ± 0.3 | 0-1 |
| Streptococcus agalactiae | — | — | — | - |
| Streptococcus pneumoniae | — | — | — | - |
| Candida albicans | 0.3 ± 1.2 | 0-4 | 0 | 0 |
| Candida species | 0.2 ± 0.4 | 0-1 | 0.1 ± 0.3 | 0-1 |
| Aspergillus species | 0.1 ± 0.3 | 0-1 | 0.1 ± 0.3 | 0-1 |
| Varicella zoster | — | — | ||
Abbreviations: MSSA, methicillin-sensitive Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus.